JG
James C Gale
Director10% Owner
James C GaleDirector10% Owner
James C Gale insider trades: Teligent (TLGT) stock buys and sales
Director, Teligent Last trade Aug 26, 2020 57 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
77
Open-market trades
since 2005
8
Companies
last trade 2020
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
TLGTTeligent
Director · last filing Sep 16, 2020
-$1.2M
+$158K
IGIgi Laboratories
Director · last filing May 1, 2015
-$51.4M
+$194K
PFNXPfenex
Director · last filing Apr 30, 2015
-$27.9M
BJCTBioject Medical Technologies
Director · last filing Jun 5, 2014
No market trades
IDEVIndevus Pharmaceuticals
Director · last filing Feb 24, 2009
-$32.2M
VLRXValera Pharmaceuticals
Director · last filing Apr 18, 2007
No market trades
and 2 more companies
Open-market buys and sales
77 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2020 | TLGT | ↓ Sell | 869,283 | $1.39 | $1.2M | Direct | Sep 16, 2020 (21d) |
| May 31, 2019 | TLGT | ↑ Buy | 20,000 | $0.66 | $13K | Direct | May 31, 2019 (0d) |
| May 23, 2019 | TLGT | ↑ Buy | 20,000 | $0.69 | $14K | Direct | May 24, 2019 (1d) |
| Nov 10, 2017 | TLGT | ↑ Buy | 15,000 | $3.81 | $57K | Direct | Nov 13, 2017 (3d) |
| Mar 11, 2016 | TLGT | ↑ Buy | 15,000 | $4.91 | $74K | Indirect | Mar 14, 2016 (3d) |
| Apr 30, 2015 | IG | ↑ Buy | 20,000 | $5.04 | $101K | Direct | May 1, 2015 (1d) |
| Apr 30, 2015 | IG | ↑ Buy | 10,000 | $5.04 | $50K | Indirect | May 1, 2015 (1d) |
| Apr 29, 2015 | PFNX | ↓ Sell | 1,907,767 | $14.57 | $27.8M | Indirect | Apr 30, 2015 (1d) |
| Mar 5, 2015 | IG | ↓ Sell | 2,000,000 | $9.95 | $19.9M | Direct | Mar 6, 2015 (1d) |
| Sep 2, 2014 | IG | ↓ Sell | 2,000,000 | $6.45 | $12.9M | Direct | Sep 4, 2014 (2d) |
| Aug 27, 2014 | IG | ↓ Sell | 3,000,000 | $6.20 | $18.6M | Direct | Aug 29, 2014 (2d) |
| Aug 22, 2014 | IG | ↑ Buy | 5,000 | $5.90 | $30K | Direct | Aug 26, 2014 (4d) |
| Jul 29, 2014 | PFNX | ↓ Sell | 380,867 | $0.31 | $118K | Indirect | Jul 31, 2014 (2d) |
| Mar 13, 2013 | IG | ↑ Buy | 10,000 | $1.33 | $13K | Direct | Mar 15, 2013 (2d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 819,821 | $7.90 | $6.5M | By Corporate Opportunity Fund (Instituti | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 634,217 | $7.90 | $5.0M | By: SMH Hydro Med, LLC | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 395,292 | $7.90 | $3.1M | By: SMH Hydro Med II, LLC | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 302,868 | $7.90 | $2.4M | By: SMH Valera, LLC | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 160,256 | $7.90 | $1.3M | By Life Sciences Opportunity Fund, L.P. | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 151,498 | $7.90 | $1.2M | By Corporate Opportunity Fund, L.P. | Oct 23, 2007 (5d) |
| Oct 18, 2007 | IDEV | ↓ Sell | 36,048 | $7.90 | $285K | By: Life Sciences Opportunity Fund (Inst | Oct 23, 2007 (5d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 34,041 | $7.30 | $248K | By: SMH Hydro Med, LLC | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 22,152 | $7.30 | $162K | By: SMH Hydro Med II, LLC | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 16,807 | $7.30 | $123K | By: SMH Valera, LLC | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 8,037 | $7.30 | $59K | By Corporate Opportunity Fund, L.P. | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 7,460 | $7.30 | $54K | By Life Sciences Opportunity Fund, L.P. | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 2,300 | $7.30 | $17K | By Corporate Opportunity Fund (Instituti | Jun 18, 2007 (3d) |
| Jun 15, 2007 | IDEV | ↓ Sell | 1,678 | $7.30 | $12K | By: Life Sciences Opportunity Fund (Inst | Jun 18, 2007 (3d) |
| Jun 14, 2007 | IDEV | ↓ Sell | 34,725 | $7.30 | $253K | By Corporate Opportunity Fund (Instituti | Jun 18, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 59,763 | $7.35 | $439K | By Corporate Opportunity Fund (Instituti | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 53,524 | $7.35 | $393K | By: SMH Hydro Med, LLC | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 34,831 | $7.35 | $256K | By: SMH Hydro Med II, LLC | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 26,427 | $7.35 | $194K | By: SMH Valera, LLC | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 11,729 | $7.35 | $86K | By Life Sciences Opportunity Fund, L.P. | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 11,088 | $7.35 | $81K | By Corporate Opportunity Fund, L.P. | Jun 11, 2007 (4d) |
| Jun 7, 2007 | IDEV | ↓ Sell | 2,638 | $7.35 | $19K | By: Life Sciences Opportunity Fund (Inst | Jun 11, 2007 (4d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 91,779 | $7.35 | $675K | By: SMH Hydro Med, LLC | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 59,725 | $7.35 | $439K | By: SMH Hydro Med II, LLC | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 45,326 | $7.35 | $333K | By: SMH Valera, LLC | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 20,112 | $7.35 | $148K | By Life Sciences Opportunity Fund, L.P. | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 19,013 | $7.35 | $140K | By Corporate Opportunity Fund, L.P. | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 17,532 | $7.36 | $129K | By Corporate Opportunity Fund (Instituti | Jun 7, 2007 (1d) |
| Jun 6, 2007 | IDEV | ↓ Sell | 4,524 | $7.35 | $33K | By: Life Sciences Opportunity Fund (Inst | Jun 7, 2007 (1d) |
| Jun 5, 2007 | IDEV | ↓ Sell | 84,986 | $7.35 | $625K | By Corporate Opportunity Fund (Instituti | Jun 7, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 78,104 | $7.37 | $576K | By: SMH Hydro Med, LLC | Jun 6, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 50,826 | $7.37 | $375K | By: SMH Hydro Med II, LLC | Jun 6, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 38,564 | $7.37 | $284K | By: SMH Valera, LLC | Jun 6, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 29,881 | $7.35 | $220K | By Corporate Opportunity Fund (Instituti | Jun 6, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 17,116 | $7.37 | $126K | By Life Sciences Opportunity Fund, L.P. | Jun 6, 2007 (2d) |
| Jun 4, 2007 | IDEV | ↓ Sell | 16,180 | $7.37 | $119K | By Corporate Opportunity Fund, L.P. | Jun 6, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James C Gale's insider trades
James C Gale is a director at Teligent (TLGT). Since Nov 4, 2005, James has reported 8 open-market purchases worth $352K and 69 sales worth $112.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), other transactions (14 filings), conversions (5 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLGT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.